Comparison of [18F]PSMA-1007 with Novel 18F-Labeled PSMA Inhibitor

被引:0
|
作者
Donat, Cornelius [1 ]
Craig, Austin [1 ]
Kogler, Juergen [1 ]
Laube, Markus [1 ]
Kopka, Klaus [1 ]
Stadlbauer, Sven [1 ]
机构
[1] Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
P-022
引用
收藏
页码:S75 / S76
页数:2
相关论文
共 50 条
  • [1] Molecular Imaging of Prostate Cancer: A direct comparison of the preclinical characteristics of [18F] DCFPyL and [18F]PSMA-1007 and the impact of glutamic acids on [18F]PSMA-1007
    Roscher, M.
    Remde, Y.
    Schaefer, M.
    Bauder-Wuest, U.
    Giesel, F.
    Neels, O. C.
    Cardinale, J.
    Kopka, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S54 - S55
  • [2] Biokinetics and radiation dosimetry of [18F]-PSMA-1007
    Hvittfeldt, E.
    Bjoersdorff, M.
    Oddstig, J.
    Svegborn, S. Leide
    Brolin, G.
    Minarik, D.
    Tragardh, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S137 - S137
  • [3] The cause of high [18F]PSMA-1007 uptake in the urinary bladder in some of the [18F]PSMA-1007 patients: an explorative, retrospective study
    Allach, Y.
    Prive, B.
    van Gemert, W.
    Schilham, M.
    Perk, L. R.
    Gotthardt, M.
    Nagarajah, J.
    Janssen, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S530 - S530
  • [4] [18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine
    Loeff, Cato C.
    van Gemert, Willemijn
    Prive, Bastiaan M.
    van Oort, Inge M.
    Hermsen, Rick
    Somford, Diederik M.
    Nagarajah, James
    Heijmen, Linda
    Janssen, Marcel J. R.
    EJNMMI REPORTS, 2024, 8 (01)
  • [5] Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors
    Piron, Sarah
    Verhoeven, Jeroen
    Courtyn, Jan
    Kersemans, Ken
    Descamps, Benedicte
    Pieters, Leen
    Vral, Anne
    Vanhove, Christian
    De Vos, Filip
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors
    Sarah Piron
    Jeroen Verhoeven
    Jan Courtyn
    Ken Kersemans
    Benedicte Descamps
    Leen Pieters
    Anne Vral
    Christian Vanhove
    Filip De Vos
    Scientific Reports, 12
  • [7] Improved synthesis and quality control of [18F]PSMA-1007
    Fasel, Antje
    Martin, Rena
    Baumgart, Diana
    Weidlich, Sebastian
    Mueller, Marco
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S226 - S227
  • [8] [18F]SuFEx-enabled access to an 18F-Labeled PSMA inhibitor intermediate
    Craig, Austin
    Kogler, Juergen
    Kopka, Klaus
    Stadlbauer, Sven
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S81 - S81
  • [9] Autoradiographic characterization of [18F]PSMA-1007 binding in rat brain
    Thomsen, Majken B.
    Landau, Anne M.
    Bender, Dirk
    Cumming, Paul
    SYNAPSE-STRUCTURE FUNCTIONS CONNECTIVITY, 2023, 77 (06):
  • [10] Fine-tuning of the automated [18F]PSMA-1007 radiosynthesis
    Shamni, Ofer
    Nebeling, Bruno
    Grievink, Hilbert
    Mishani, Eyal
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 (06): : 252 - 258